Companies with a Future performance score of at least 3, ordered by Future performance score.
Advicenne S.A., a late-stage biopharmaceutical company, develops pediatric therapeutics for the treatment of orphan renal diseases and niche neurology indications.
ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops, markets, and commercializes treatments for the treatment of autoimmune diseases, viral infections, and cancer in France.
Valneva SE, a specialty vaccine company, engages in developing and commercializing vaccines for infectious diseases with unmet needs.
Poxel S.A., a biopharmaceutical company, develops drugs for metabolic diseases with primary focus on type II diabetes.
Onxeo SA, a clinical-stage biotechnology company, designs and develops oncology drugs for tumor DNA repair functions worldwide.
GeNeuro SA, a clinical-stage biopharmaceutical company, develops drugs for the treatment of neurodegenerative and autoimmune diseases.
Theranexus société anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders.
Ipsen S.A. operates as a biopharmaceutical company worldwide.
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally.
Pharnext SA, a clinical-stage biopharmaceutical company, develops therapeutics for severe orphan and common neurodegenerative diseases in France.
Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide.